Summary

This document outlines the strategic, in-market, and executional expertise that pharmaceutical and life science companies demand to achieve successful regulatory outcomes. Additionally, a revised set of updated guidelines has been issued by AIFA, which includes clearer classification criteria for non-prescription medicines.

Title

Regulatory Pharma Net

Description

Your trusted partner to maximize the potential of your healthcare solutions

Keywords

market, insights, access, event, policy, solutions, affairs, medical, life, companies, expertise, more, convention, europe, medicines, devices, publications

NS Lookup

A 86.107.36.73

Dates

Created 2026-03-09

Updated 2026-04-05

Summarized 2026-04-05